Found: 32
Select item for more details and to access through your institution.
Lenalidomide-Associated Secondary B-Lymphoblastic Leukemia/Lymphoma-A Unique Entity.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Final analysis of a phase 1/2b study of ibrutinib combined with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Health‐related quality of life in transplant‐eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient‐reported outcomes from GRIFFIN.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 7, p. 1257, doi. 10.1002/ajh.27326
- By:
- Publication type:
- Article
Architecture and fiber type of the pyramidalis muscle.
- Published in:
- Anatomical Science International, 2008, v. 83, n. 4, p. 294, doi. 10.1111/j.1447-073X.2007.00226.x
- By:
- Publication type:
- Article
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide‐pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 1, p. 73, doi. 10.1111/ejh.13706
- By:
- Publication type:
- Article
Leptomeningeal plaques, a 'common' finding.
- Published in:
- Clinical Anatomy, 2006, v. 19, n. 8, p. 696, doi. 10.1002/ca.20373
- By:
- Publication type:
- Article
P-224: Pomalidomide, bortezomib, and dexamethasone after 1 prior line of therapy in relapsed or refractory multiple myeloma (RRMM): A safety subanalysis of the phase 3 OPTIMISMM trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S163, doi. 10.1016/S2152-2650(21)02351-X
- By:
- Publication type:
- Article
P-180: Daratumumab (DARA) Plus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in newly diagnosed Multiple Myeloma (NDMM): analysis of vascular thrombotic events (VTEs) in the GRIFFIN study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S135, doi. 10.1016/S2152-2650(21)02307-7
- By:
- Publication type:
- Article
OAB-027: Idecabtagene vicleucel (ide-cel, bb2121), a BCMA-directed CAR T-cell therapy, for the treatment of patients with relapsed and refractory multiple myeloma (RRMM): updated results from KarMMa.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S17, doi. 10.1016/S2152-2650(21)02101-7
- By:
- Publication type:
- Article
MM-392: Belantamab Mafodotin (Belamaf; GSK2857916) US Expanded Access Program (EAP) for Heavily Pre-Treated Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Baseline Characteristics.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S439, doi. 10.1016/S2152-2650(21)01979-0
- By:
- Publication type:
- Article
Poster: MM-392: Belantamab Mafodotin (Belamaf; GSK2857916) US Expanded Access Program (EAP) for Heavily Pre-Treated Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Baseline Characteristics.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S252, doi. 10.1016/S2152-2650(21)01579-2
- By:
- Publication type:
- Article
Pomalidomide + Bortezomib + Dexamethasone After One Prior Line of Therapy in Bortezomib-Pretreated Multiple Myeloma: Subanalysis of OPTIMISMM.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e32, doi. 10.1016/j.clml.2019.09.048
- By:
- Publication type:
- Article
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01088-6
- By:
- Publication type:
- Article
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01030-w
- By:
- Publication type:
- Article
Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01034-6
- By:
- Publication type:
- Article
Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00937-0
- By:
- Publication type:
- Article
Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00886-8
- By:
- Publication type:
- Article
Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN.
- Published in:
- 2022
- By:
- Publication type:
- Letter
KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myeloma.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 6, p. 1, doi. 10.1038/s41408-021-00507-2
- By:
- Publication type:
- Article
DNA Immunization Against Amyloid beta 42 has High Potential as Safe Therapy for Alzheimer's Disease as it Diminishes Antigen-Specific Th1 and Th17 Cell Proliferation.
- Published in:
- Cellular & Molecular Neurobiology, 2011, v. 31, n. 6, p. 867, doi. 10.1007/s10571-011-9680-7
- By:
- Publication type:
- Article
A case of benign immunoglobulin D monoclonal gammopathy of undetermined significance with 26 years of follow‐up.
- Published in:
- EJHaem, 2024, v. 5, n. 1, p. 235, doi. 10.1002/jha2.846
- By:
- Publication type:
- Article
Editorial: T-cell directed therapies in multiple myeloma.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1206475
- By:
- Publication type:
- Article
Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN study.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 6, p. 2227, doi. 10.1111/bjh.19386
- By:
- Publication type:
- Article
Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 3, p. 355, doi. 10.1111/bjh.18432
- By:
- Publication type:
- Article
Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 6, p. 821, doi. 10.1111/bjh.15058
- By:
- Publication type:
- Article
Lead effects on protamine-DNA binding.
- Published in:
- American Journal of Industrial Medicine, 2000, v. 38, n. 3, p. 324, doi. 10.1002/1097-0274(200009)38:3<324::AID-AJIM12>3.0.CO;2-R
- By:
- Publication type:
- Article
Patient perspectives on BCMA-targeted therapies for multiple myeloma: a survey conducted in a patient advocacy group.
- Published in:
- Frontiers in Health Services, 2024, p. 01, doi. 10.3389/frhs.2024.1354760
- By:
- Publication type:
- Article
Clinical Features and Risk Stratification of Multiple Myeloma Patients with COVID-19.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3598, doi. 10.3390/cancers15143598
- By:
- Publication type:
- Article
Preface of the Special Issue "COVID-19 Infection and Hematological Malignancies".
- Published in:
- 2022
- By:
- Publication type:
- Editorial
SARS-CoV-2 Vaccination IgG Antibody Responses in Patients with Hematologic Malignancies in a Myeloid Enriched Cohort: A Single Center Observation.
- Published in:
- Acta Medica Academica, 2023, v. 52, n. 1, p. 30, doi. 10.5644/ama2006-124.399
- By:
- Publication type:
- Article
Outcomes of therapeutic plasma exchange for the treatment of patients with multiple myeloma cast nephropathy.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3293
- By:
- Publication type:
- Article
Coupled physical and digital cadaver dissection followed by a visual test protocol provides insights into the nature of anatomical knowledge and its evaluation.
- Published in:
- Anatomical Sciences Education, 2008, v. 1, n. 1, p. 27, doi. 10.1002/ase.4
- By:
- Publication type:
- Article